Date: Jan-2019 | Id: MACRC-0841 | Geographical Scope: Global
This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Anti-CD40 Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key obje...
Date: Jan-2019 | Id: MACRC-0840 | Geographical Scope: Global
This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Anti-CD38 Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key obje...
Date: Jan-2019 | Id: MACRC-0839 | Geographical Scope: Global
This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Anti-CD37 Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key obje...
Date: Jan-2019 | Id: MACRC-0838 | Geographical Scope: Global
This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Anti-CD33 Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key obje...
Date: Jan-2019 | Id: MACRC-0837 | Geographical Scope: Global
This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Anti-CD3 Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key objec...
Date: Jan-2019 | Id: MACRC-0836 | Geographical Scope: Global
This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Anti-CD28 Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key obje...
Date: Jan-2019 | Id: MACRC-0835 | Geographical Scope: Global
This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Anti-CD279 (PD-1) Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A ...
Date: Jan-2019 | Id: MACRC-0834 | Geographical Scope: Global
This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Anti-CD274 (PD-L1) Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A...
Date: Jan-2019 | Id: MACRC-0833 | Geographical Scope: Global
This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Anti-CD19 Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key obje...
Date: Jan-2019 | Id: MACRC-0832 | Geographical Scope: Global
This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Anti-CD152 Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key obj...